跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Natronem - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Natronem
Approved
STANDARD
Natronem
Samjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c4d0f8f370b6b2b
Company
Samjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
2c4d0f8f370b6b2b
Drug Approval Philippines Name
Natronem
Product Name
Natronem
Registration Number
DR-XY43763
Brand Name
Natronem
Generic Name
Meropenem (as trihydrate)
Dosage Form
Powder for Injection (IV)
Dosage Strength
500 mg
Manufacturer
Samjin Pharmaceutical Co., Ltd.
Importer
Patriot Pharmaceuticals Corporation
Distributor
Patriot Pharmaceuticals Corporation
Company Detail Path
/organization/samjin-pharmaceutical-co-ltd
Issuance Date
28 August 2024
Expiry Date
29 October 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c4d0f8f370b6b2b
Type
Standard
Back to Philippines FDA Approvals